Navigation Links
Trenton, New Jersey's Boehm Porcelain Art Studio, Preeminent Maker of Fine Porcelain in America, Has Been Saved by a New American Owner-Investor
Date:5/4/2009

TRENTON, N.J., May 4 /PRNewswire/ -- On Sunday, May 3rd noon to five p.m., the Boehm American Porcelain Company open house introduced Sharon Lee Parker, the new president of the company, who has a loving decades-long history as ardent collector and a booster of Boehm's distinguished American roots. Continuing American stewardship is now assured for this heralded studio, prized by leading museums, collectors, and the art and nature loving public the world over for its pursuit of perfection.

Determined to enable our country to keep this home-bred art tradition in its original 1949 Trenton studio and manufacturing center and prevent our country from losing one of the nation's major cultural assets to overseas interests, Ms. Parker stepped up, along with a few other Boehm lovers, to acquire the company. Parker was a close friend of Helen Boehm, wife of founder Edwin Marshall Boehm, who became a legendary figure introducing the company's magical line of porcelain art sculptures worldwide.

Boehm's fine, hand made and hand painted sculptures are represented at the White House, presidential libraries, and the Vatican; and bring joy to scores of prominent sites including Buckingham Palace, Elysee Palace, the Smithsonian, Kennedy Center, Blair House, American embassies and universities, hospitals, and fine art galleries. Boehm's exquisite porcelain replicas of floral and animal life created by generations of skilled American artisans are also available online and at leading retail outlets around the globe.

"A Boehm creation is a forever gift," Ms. Parker proudly stated. "Once in possession of a treasured Boehm piece, large or small, that is in need of repair owners can send it back. Without fail, it will be restored to its original, state-of-the-art perfection. Retaining skilled craftsmanship, as well as these dedicated Boehm craftsman and their families in America, is of paramount importance to Ms. Parker and our nati
'/>"/>

SOURCE BOEHM AMERICAN PORCELAIN
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine news :

1. World Health Care Congress to convene preeminent leaders for 3 days on rebuilding health care
2. 6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care
3. Dorsey Schools, Detroit Areas Preeminent Career Training School, Opens a Fifth Campus in Farmington Hills
4. The Makers of BENADRYL(R) and the National Park Foundation Encourage People to Pledge to Spend More Time Enjoying Outdoor Moments
5. 84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare Competitive Bidding Rule Before April 18 Deadline
6. Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare Competitive Bidding Rule
7. National Press Club to Host NEWSMAKER Media Briefing on Taiwans Experience in National Health Care Insurance
8. California Moms to Lawmakers: Health Care Coverage is a Lifesaver for California Families
9. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Celebrates 25 Years of Improving Patient Care
10. FDA Warns Drug Makers to Stop Selling Unapproved Prescription Painkillers
11. Disabled Veterans Leader Presses Issues with Key Lawmakers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...e/ -- Reportlinker.com announces that a new market..., Emerging Clinical Trial Locations - India: M...ulatory environment ,, http://www.reportlink...--India-Market-dynamics-and-the-changing-healthcar...last decade pharmaceutical and biotechnology compa...
(Date:12/1/2009)...e-USNewswire/ -- A scientist who broadened the und...e can control and relieve it -- has won the 2010 U...ology. ,, Ronald Melzack, psychology professor ...ected for the award from among 24 nominations. ,... instead in their brain through a pathway that tra...
(Date:12/1/2009)... (CT) imaging to analyze form and structural chang...b and chemotherapy may predict overall survival, a...M. D. Anderson Cancer Center. , The findings are... combined with chemotherapy, the angiogenesis inhi...iated with both improved survival in those with me...
(Date:12/1/2009)... -- The government of Mexico City today announced ...and nanomedical research, called Campus Biometropo...ent will be integrated with the National Autonomou...niversity in the world. The research complex, sch...igned by the internationally-acclaimed architectur...
(Date:12/1/2009)...screening test, expert says , , TUESDAY,...d lead to a simple blood test to screen for lung c...tem markers that indicate early-stage lung tumors ...esearchers examined gene expression profiles in bl...ung cancer and a control group of 91 people with n...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Scientist Who Helps Explain Pain Wins Grawemeyer Award 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 2Health News:CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 3Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Gene 'Signature' May Point to Lung Cancer 2
...ll on their own to tackle issue , , WEDNES...net Earth is "the biggest global health threat of ...d Wednesday. , Their report is one of the latest t...problem. , "This is a bad diagnosis not just for...
...d Giving Held Their Own as Downturn Took Hold , ,...ened on nonprofit hospitals and health care system...ropic fundraisers in charge of major gifts and pla...These and other important findings come from the l...
...14 Catalyst Pharmaceutical Partners, Inc. (Nasdaq...e first quarter ended March 31, 2009. , , Firs...d March 31, 2009, the Company reported a net loss ...n 2008. First quarter 2009 results included non-ca...
...les Superior Dose Calculation with Unmatched Speed...y more accurate* way of calculating the dosimetry ...Medical Systems (NYSE: VAR ) at the GEC-ESTRO ex...nts (a form of radiotherapy) with an extremely hig...
...4 Palomar Medical Technologies, Inc. (Nasdaq: P...-based systems for cosmetic treatments, announced ... held at the European Patent Office on May 6 and 1...8 and 5,735,844. This light-based hair removal pa...
... Interleukin Genetics, Inc. (NYSE Amex: ILI )...ff of the NYSE Amex LLC (the "Exchange") has accep...inued listing standards, and has granted the compa...before the Listing Qualifications Panel, as discus...
Other Medicine News:Health News:Global Warming Biggest Health Threat of 21st Century, Experts Say 2Health News:Global Warming Biggest Health Threat of 21st Century, Experts Say 3Health News:Hire More Fundraising Rain-Makers During Recession, New AHP Study Concludes 2Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 2Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 3Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 4Health News:Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results 5Health News:Varian Medical Systems Introduces Fast and Precise Brachytherapy Planning System at GEC-ESTRO in Portugal 2Health News:Varian Medical Systems Introduces Fast and Precise Brachytherapy Planning System at GEC-ESTRO in Portugal 3Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 2Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 3Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 4Health News:NYSE Amex Accepts Interleukin Genetics' Plan to Meet Continued Listing Standards 2
(Date:12/1/2009)... , INDIANAPOLIS, Dec. 1 /PRNewswire-... of Medicine, Improving Health... Improving Life,"...able at www.lillyforbetterhealth.com/value_of_med...t to providing "Answers That Matter" and encourage...s and the public about pharmaceutical industry pra...
(Date:12/1/2009)..., NEW YORK, Dec. 1 WebMD... of health information, today announced the honore...rth annual WebMD Health Heroes honor Americans wit...rseverance, who lead an effort to help others achi...newscom.com/cgi-bin/prnh/20091201/NY18114 ) ,,...
(Date:12/1/2009)...MT. LAUREL, N.J., Dec. 1 /PRNewswire-FirstCall/ ...der of technology-enabled clinical documentation s... tool from Primordial Design, Inc. has been integr...al-time speech recognition system. The solution is... North America (RSNA) convention November 29 throu...
Breaking Medicine Technology:Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Nano measurement in the third dimension 12903 1Nano measurement in the third dimension 12903 2New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 1Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 2
...swire/ -- Once-daily,dosing with Otsuka,s investig...eceptor antagonist, was associated with improvemen...heart failure (ADHF),in hospitalized patients rece... on their long-term survival versus placebo.(1) Th...s of the,international landmark trial Efficacy of ...
... Holds Promise as,Future-Generation Treatment Opti...Artery Disease, ABBOTT PARK, Ill., March 24, 2007 ...ositive results from ABSORB, the world,s,first cli...ormance,of a fully bioabsorbable drug- eluting ste...isease. Six- month results from the,first 30 patie...
Other Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3
VersaStep™ Plus Instrument
...e Step™ and Mini Step™ device componen...ini Step™ Single Use System is supplied ster...n various configurations and combinations. They ar...ation and Access needle and the Step™ radial...
...e Step™ and Mini Step™ device componen...ini Step™ Single Use System is supplied ster...n various configurations and combinations. They ar...ation and Access needle and the Step™ radial...
...e VersaStep™ 5 mm and VersaStep™ PLUS ...ss port are supplied in separate packages. The ra...r with either a 5 mm or 5 mm PLUS valve. Insuffla... mm, 7/8 mm, 10 mm and 12 mm dilators are packaged...
Medicine Products: